(Q33385516)

26 July 2017

Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations (English)

1 reference

inflammatory bowel diseases

26 July 2017

0 references

Susan M Hutfless

7

0 references

Lisa J Herrinton

9

object named as

Lisa J Herrinton

1 reference

26 July 2017

James D Lewis

1

1 reference

26 July 2017

Oren Abramson

2

1 reference

26 July 2017

Monina Pascua

3

1 reference

26 July 2017

Liyan Liu

4

1 reference

26 July 2017

Laura M Asakura

5

1 reference

26 July 2017

Fernando S Velayos

6

1 reference

26 July 2017

James E Alison

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

22 July 2009

1 reference

Clinical Gastroenterology and Hepatology

26 July 2017

1 reference

26 July 2017

7

1 reference

26 July 2017

11

1 reference

26 July 2017

1195-201; quiz 1141-2

1 reference

Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Review article: practical management of inflammatory bowel disease patients taking immunomodulators

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4435979

Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19631285

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19631285

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19631285

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CGH.2009.07.019

1 reference

26 July 2017

1 reference

26 July 2017

1 reference